2
ETCHEM10675
Clinical Trials AK
Preface
1
Introduction
2
ETCHEM10675
3
ABNL-MARRO
4
ABNL-MARRO Arm A
5
ABNL-MARRO Arm B
6
A Phase 1/2, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients With Intermediate or High-Risk Primary or Secondary Myelofibrosis
7
INCB160058-101 trial HEM 24055
8
HEM 24599_Elritercept
9
Weekly low-dose regimen of decitabine and venetoclax
10
AU-018 Clinical Trial
11
Summary
References
Table of contents
2.1
A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)
2
ETCHEM10675
2.1
A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)
1
Introduction
3
ABNL-MARRO